Loading clinical trials...

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01283087

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Lead sponsor: Vestre Viken Ringerike Sykehus•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet Recruiting

Prospective Registry of Vertigo Due to Vertebrobasilar Transient Attacks.

NCT07421973 · Vertigo, Dizziness, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 27, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment168

Start dateJan 2011

Last updatedNov 27, 2017

Condition

Transient Neurologic Symptoms

Locations shown

Ringerike Sykehus

Hønefoss

Vestre Viken HF Ringerike Sykehus

Hønefoss

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 27, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions